Junjie Feng
Systematic identification of genetic variants within AR binding sites that are associated with altered AR signaling and prostate cancer Androgen Receptor (AR) mediates the action of the male hormones, androgens...Read More
Andrea Harzstark
Dr. Harzstark earned a BS degree in Biological Sciences and an MD degree from Stanford University. She is currently a Fellow in Hematology and Oncology at UCSF. Immunotherapy offers the...Read More
Dimple Chakravarty
Nanotargeting Estrogen Receptor regulated Long Non Coding RNA in prostate cancer progression Androgens and Androgen Receptor (AR) fuel prostate cancer. Therefore, androgen deprivation therapy (ADT) is usually the preferred treatment...Read More
Airi Harui
Dr. Harui earned a BS in Pharmaceutical Sciences at University of Kobegakuin in Kobe, Japan and her MSc in Pharmaceutical Sciences from the University of Osaka. She earned her PhD...Read More
Thomas Guzzo
Dr. Guzzo earned a BS in Biology from Ursinus College and an MD from Temple University School of Medicine. He is currently a Urologic Oncology Fellow and clinical instructor at...Read More
Jeremy Durack
Prostate cancer diagnosis and precision medicine treatment decisions currently rely on results from invasive biopsy procedures. Current biopsy methods do not ensure that the quality of the sample collected is...Read More
Shalini S. Yadav
Growing clinical evidence suggests that a majority of cancer patients present with “intratumoral heterogeneity”—that is, not only do tumors at one site in their body differ from those at another,...Read More
Steven Frank
Dr. Frank earned his certification in Nuclear Engineering from the United States Naval Nuclear Propulsion Program and an MD degree from Emory University. He completed a Fellowship in Radiation Oncology...Read More
Eliezer Van Allen, MD
Dr. Eliezer Van Allen is an Assistant Professor of Medicine at Harvard Medical School, the Computational Director for the Center for Cancer Precision Medicine at Dana-Farber Cancer Institute, and Associate...Read More